Last month, Pfizer reported its coronavirus antiviral drug is 89% effective at stopping hospitalizations and deaths in high-risk Covid-19 patients.
Last month, Pfizer reported its coronavirus antiviral drug is 89% effective at stopping hospitalizations and deaths in high-risk Covid-19 patients.